Home > Publications database > Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC). > print |
001 | 132790 | ||
005 | 20240229105032.0 | ||
024 | 7 | _ | |a 10.1074/mcp.RA117.000189 |2 doi |
024 | 7 | _ | |a pmid:29363612 |2 pmid |
024 | 7 | _ | |a pmc:PMC5880102 |2 pmc |
024 | 7 | _ | |a 1535-9476 |2 ISSN |
024 | 7 | _ | |a 1535-9484 |2 ISSN |
024 | 7 | _ | |a altmetric:32129084 |2 altmetric |
037 | _ | _ | |a DKFZ-2018-00434 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 540 |
100 | 1 | _ | |a Buczak, Katarzyna |b 0 |
245 | _ | _ | |a Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC). |
260 | _ | _ | |a Bethesda, Md. |c 2018 |b The American Society for Biochemistry and Molecular Biology |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1659533820_29251 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a The interpatient variability of tumor proteomes has been investigated on a large scale but many tumors display also intratumoral heterogeneity regarding morphological and genetic features. It remains largely unknown to what extent the local proteome of tumors intrinsically differs. Here, we used hepatocellular carcinoma as a model system to quantify both inter- and intratumor heterogeneity across human patient specimens with spatial resolution. We defined proteomic features that distinguish neoplastic from the directly adjacent nonneoplastic tissue, such as decreased abundance of NADH dehydrogenase complex I. We then demonstrated the existence of intratumoral variations in protein abundance that re-occur across different patient samples, and affect clinically relevant proteins, even in the absence of obvious morphological differences or genetic alterations. Our work demonstrates the suitability and the benefits of using mass spectrometry-based proteomics to analyze diagnostic tumor specimens with spatial resolution. Data are available via ProteomeXchange with identifier PXD007052. |
536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Ori, Alessandro |b 1 |
700 | 1 | _ | |a Kirkpatrick, Joanna M |b 2 |
700 | 1 | _ | |a Holzer, Kerstin |b 3 |
700 | 1 | _ | |a Dauch, Daniel |b 4 |
700 | 1 | _ | |a Roessler, Stephanie |b 5 |
700 | 1 | _ | |a Endris, Volker |b 6 |
700 | 1 | _ | |a Lasitschka, Felix |b 7 |
700 | 1 | _ | |a Parca, Luca |b 8 |
700 | 1 | _ | |a Schmidt, Alexander |b 9 |
700 | 1 | _ | |a Zender, Lars |0 P:(DE-He78)1ba2900406378e069d32db376c7818db |b 10 |u dkfz |
700 | 1 | _ | |a Schirmacher, Peter |b 11 |
700 | 1 | _ | |a Krijgsveld, Jeroen |0 P:(DE-He78)939d5891259c638c1ab053b1456a578c |b 12 |u dkfz |
700 | 1 | _ | |a Singer, Stephan |b 13 |
700 | 1 | _ | |a Beck, Martin |b 14 |
773 | _ | _ | |a 10.1074/mcp.RA117.000189 |g Vol. 17, no. 4, p. 810 - 825 |0 PERI:(DE-600)2071375-7 |n 4 |p 810 - 825 |t Molecular & cellular proteomics |v 17 |y 2018 |x 1535-9484 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:132790 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)1ba2900406378e069d32db376c7818db |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)939d5891259c638c1ab053b1456a578c |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
914 | 1 | _ | |y 2018 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MOL CELL PROTEOMICS : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b MOL CELL PROTEOMICS : 2015 |
920 | 1 | _ | |0 I:(DE-He78)V076-20160331 |k V076 |l Translationale Gastrointestinale Onkologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B230-20160331 |k B230 |l B230 Proteomik |x 1 |
920 | 1 | _ | |0 I:(DE-He78)L801-20160331 |k L801 |l DKTK Tübingen |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)V076-20160331 |
980 | _ | _ | |a I:(DE-He78)B230-20160331 |
980 | _ | _ | |a I:(DE-He78)L801-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|